Home > Investors
Investor Relations Home
E-mail Page Print Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet 
About Us
Webcast ImageWebcast - Live
The Medicines Company at Jefferies 2015 Global Healthcare Conference
06/01/15 at 10:00 a.m. ET
Webcast ImageWebcast - Replay
The Medicines Company at Bank of America Merrill Lynch 2015 Health Care Conference
05/14/15 at 10:00 a.m. PT
Webcast ImageWebcast - Replay
Q1 2015 The Medicines Company Earnings Conference Call
05/05/15 at 8:30 a.m. ET
Webcast ImageWebcast - Replay
The Medicines Company at Cowen and Company 35th Annual Health Care Conference
03/03/15 at 8:40 a.m. ET
Corporate Profile
The Medicines Company provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients.
Stock Quote
MDCO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$28.36
Change (%) Stock is Up 0.22 (0.78%)
Volume1,381,432
Data as of 05/29/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News
DateTitle 
05/26/15The Medicines Company Presents New Data Showing Remodeling Effect of MDCO-216 on HDL Particles in Coronary Artery Disease Patients
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 26, 2015-- The Medicines Company (NASDAQ:MDCO) presented the results of a Phase 1 study for MDCO-216 that showed that the drug had a significant remodeling effect on HDL particles, which correlated with increased ABCA1-mediated cholesterol efflux. This mechanism of HDL remodeling and increased cholesterol efflux may drive the removal of deposited cholesterol from vessel walls to reduce plaque burden in patients with... 
Printer Friendly Version
05/22/15The Medicines Company to participate in the Jefferies 2015 Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Jefferies 2015 Healthcare Conference in New York, NY on Monday, June 1, 2015 at 10:00 AM EDT. The session will be webcast with a link available at The Medicines Company’s website http://www.themedicinescompany.com. About The Medicines Company The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute... 
Printer Friendly Version
05/07/15The Medicines Company to Participate in Bank of America Merrill Lynch 2015 Health Care Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 7, 2015-- The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Bank of America Merrill Lynch 2015 Health Care Conference in Las Vegas, NV on Thursday, May 14, 2015 at 10:00 AM PT. The session will be webcast with a link available at The Medicines Company’s website http://www.themedicinescompany.com. About The Medicines Company The Medicines Company's purpose is to save li... 
Printer Friendly Version
05/05/15The Medicines Company Reports First Quarter 2015 Financial Results and Operational Developments
Company records six regulatory approvals in US and EU in 2015 PARSIPPANY, N.J.--(BUSINESS WIRE)--May 5, 2015-- The Medicines Company (NASDAQ:MDCO) today announced financial results for the first quarter of 2015 and operational developments for 2015. Operational highlights: IONSYS® – on April 30, 2015, the FDA approved IONSYS® (fentanyl iontophoretic transdermal system), the first needle-free, patient-controlled, p... 
Printer Friendly Version
Upcoming Events
DateTitle
06/01/15 10:00 a.m. ET
The Medicines Company at Jefferies 2015 Global Healthcare Conference

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.